RUPERTO NICOLINO

Ruolo:
Professore ordinario
Settore scientifico disciplinare:
Pediatria generale e specialistica (MEDS-20/A)
Gruppo scientifico disciplinare:
PEDIATRIA GENERALE E SPECIALISTICA E NEUROPSICHIATRIA INFANTILE (06/MEDS-20)
E-mail:
[email protected]

Pubblicazioni

  • La Bella, S., Alongi, A., Filocamo, G., Cattalini, M., Lanni, S., Marino, A., et al. (2026). Environmental determinants of juvenile idiopathic arthritis: current evidence and future directions. GLOBAL PEDIATRICS, 16(June 2026) [10.1016/j.gpeds.2026.100336]. Dettaglio

  • La Bella, S., Rebollo-Gimenez, A., Alongi, A., Capitoli, G., Breda, L., La Torre, F., et al. (2026). The role of artificial intelligence in clinical trials in adult and pediatric rheumatology. CURRENT OPINION IN IMMUNOLOGY, 102(October 2026) [10.1016/j.coi.2026.102818]. Dettaglio

  • La Bella, S., Rebollo-Giménez, A., Aouad, K., Gupta, L., Kragstrup, T., Bayraktar, D., et al. (2026). Artificial intelligence in rheumatology and paediatric rheumatology: insights from an international survey by EMEUNET. EULAR RHEUMATOLOGY OPEN, 2(2 (June 2026)) [10.1016/j.ero.2026.03.001]. Dettaglio

  • Mastrolia, M., Pandiarajan, V., Cattalini, M., Taddio, A., Vergnano, S., Anton, J., et al. (2026). Predictive value for intravenous immunoglobulin resistance of Kobayashi and Kawanet scores in 722 children with Kawasaki disease across diverse ethnic backgrounds (KIWI study): an international cohort study. ECLINICALMEDICINE, 93(March 2026) [10.1016/j.eclinm.2026.103813]. Dettaglio

  • Brunner, H., Alexeeva, E., Bandeira, M., Carrasco, R., Chaitow, J., Chiraseveenuprapund, P., et al. (2026). Tofacitinib for the Treatment of Juvenile Idiopathic Arthritis: Patient-Reported Outcomes in a Phase 3, Randomized, Double-Blind, Placebo-Controlled Withdrawal Trial. ARTHRITIS & RHEUMATOLOGY, 78(3), 752-762 [10.1002/art.43428]. Dettaglio

Lista completa